Diphosphonium ionic liquids as broad-spectrum antimicrobial agents

Cornea

Volumn 31, Issue 7, 2012, Pages 810-816

  O'Toole, George A ^a   Wathier, Michel ^b   Zegans, Michael E ^a   Shanks, Robert M Q ^c   Kowalski, Regis ^c   Grinstaff, Mark W ^b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b BOSTON UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

antimicrobial agents; cornea; ionic liquids; keratitis; ocular

Indexed keywords

ANTIINFECTIVE AGENT; DICATIONIC BISPHOSPHONIUM IONIC LIQUID; IONIC LIQUID; PHOSPHONIUM 1 (1 DECANEDIYL)[1,1,1 TRIHEXYL] CHLORIDE; PHOSPHONIUM 1,19 (1,10 DECANEDIYL)BIS[1,1,1 TRIBUTYL] CHLORIDE; PHOSPHONIUM 1,19 (1,10 DECANEDIYL)BIS[1,1,1 TRIHEXYL] CHLORIDE; PHOSPHONIUM 1,19 (1,10 DECANEDIYL)BIS[1,1,1 TRIOCTYL] CHLORIDE; PHOSPHONIUM 1,19 (1,6 HEXANEDIYL)BIS[1,1,1 TRIBUTYL] CHLORIDE; PHOSPHONIUM 1,19 (1,6 HEXANEDIYL)BIS[1,1,1 TRIOCTXYL] CHLORIDE; PHOSPHONIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; BACTERICIDAL ACTIVITY; CANDIDA ALBICANS; CHEMICAL STRUCTURE; CORNEA CELL; CORNEA INJURY; CYTOTOXICITY; DRUG STABILITY; DRUG SYNTHESIS; EPITHELIUM CELL; FUNGAL EYE INFECTION; FUSARIUM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KLEBSIELLA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS EPIDERMIDIS; VERTICILLIUM;

ANIMALS; ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; CORNEAL ULCER; DISEASE MODELS, ANIMAL; EYE INFECTIONS, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICROBIAL SENSITIVITY TESTS; ORGANOPHOSPHORUS COMPOUNDS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84862863788     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31823f0a86     Document Type: Article

References (33)

1. Arias CA, Murray BE. Emergence and management of drug-resistant enterococcal infections. Expert Rev Anti Infect Ther. 2008;6:637-655.
2. Oteo J, Cuevas O, Navarro C, et al. Trends in antimicrobial resistance in 3469 enterococci isolated from blood (EARSS experience 2001-06, Spain): increasing ampicillin resistance in Enterococcus faecium. JAnti-microb Chemother. 2007;59:1044-1045. (Pubitemid 47073387)
3. Livermore DM. Future directions with daptomycin. JAntimicrob Chemother. 2008;62(suppl 3):iii41-iii49.
4. Lopez Marti MG, Jhaveri R. Bacteremia caused by an Enterococcus faecalis isolate with high-level linezolid resistance in a teenager with Crohn's disease. Pediatr Infect Dis J. 2009;28:663-664.
5. Feng J, Lupien A, Gingras H, et al. Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance. Genome Res. 2009;19:1214-1223.
6. Tenover FC, Goering RV. Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. J Antimicrob Chemother. 2009;64:441-446.
7. Nicasio AM, Kuti JL, Nicolau DP. The current state of multidrug-resistant gram-negative bacilli in North America. Pharmacotherapy. 2008;28:235-249.
8. Giamarellou H, Kanellakopoulou K. Current therapies for Pseudomonas aeruginosa. Crit Care Clin. 2008;24:261-278; viii. (Pubitemid 351400616)
9. Siegel RE. Emerging gram-negative antibiotic resistance: daunting challenges, declining sensitivities, and dire consequences. Respir Care. 2008; 53:471-479.
10. Fintelmann RE, Hoskins EN, Lietman TM, et al. Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures. Arch Ophthalmol. 2011;129:399-402.
11. Almeida DR, Miller D, Alfonso EC. Anterior chamber and vitreous concordance in endophthalmitis: implications for prophylaxis. Arch Ophthalmol. 2010;128:1136-1139.
12. Chaudhry NA, Flynn HW Jr, Murray TG, et al. Emerging ciprofloxacin- resistant Pseudomonas aeruginosa. Am J Ophthalmol. 1999;128: 509-510. (Pubitemid 29479329)
13. Gipson IK, Spurr-Michaud S, Argueso P, et al. Mucin gene expression in immortalized human corneal-limbal and conjunctival epithelial cell lines. Invest Ophthalmol Vis Sci. 2003;44:2496-2506. (Pubitemid 36618406)
14. Lee A, Chow D, Haus B, et al. Airway epithelial tight junctions and binding and cytotoxicity of Pseudomonas aeruginosa. Am J Physiol. 1999;277:L204-L217. (Pubitemid 29356769)
15. Zaki I, Fitzgerald P, Hardy JG, et al. A comparison of the effect of viscosity on the precorneal residence of solutions in rabbit and man. J Pharm Pharmacol. 1986;38:463-466. (Pubitemid 16081897)
16. Rogers RD, Seddon KR. Chemistry. Ionic liquids\-solvents of the future? Science. 2003;302:792-793.
17. Rogers RD. Materials science: reflections on ionic liquids. Nature. 2007; 447:917-918. (Pubitemid 46978258)
18. Wilkes JS. Properties of ionic liquid solvents for catalysis. J Mol Catal Chem. 2004;214:11-17.
19. Welton T. Room-temperature ionic liquids. Solvents for synthesis and catalysis. Chem Rev. 1999;99:2071-2084.
20. Binnemans K. Ionic liquid crystals. Chem Rev. 2005;105:4148-4204. (Pubitemid 41741653)
21. Welton T. Ionic liquids in catalysis. Coord Chem Rev. 2004;248: 2459-2477.
22. Wasserscheid P, Welton T. Ionic Liquids in Synthesis. Weinheim, Germany: Wiley-VCH; 2003.
23. Ding J, Armstrong DW. Chiral ionic liquids: synthesis and applications. Chirality. 2005;17:281-292. (Pubitemid 40617154)
24. Cocalia VA, Gutowski KE, Rogers RD. The coordination chemistry of actinides in ionic liquids: a review of experiment and simulation. Coord Chem Rev. 2006;250:755-764.
25. Ohno H. Ionic Liquids: The Front and Future of Material Developments. Tokyo: CMC; 2003.
26. Dupont J, de Souza RF, Suarez PA. Ionic liquid (molten salt) phase organometallic catalysis. Chem Rev. 2002;102:3667-3692. (Pubitemid 35353956)
27. Harvey AH, Levelt Sengers JM. Comment on "Liquid-liquid phase separation and critical exponents in ionic fluid mixtures". Phys Rev A. 1992; 46:1148-1149.
28. Meindersma GW, Podt A, Meseguer MG, et al. Ionic liquids: fundamentals, progress, challenges and opportunities. Transformations Processes. 2005;902:57-71.
29. Wathier M, Grinstaff MW. Synthesis and properties of supramolecular ionic networks. J Am Chem Soc. 2008;130:9648-9649.
30. Wathier M, Grinstaff MW. Synthesis and creep-recovery behavior of a neat viscoelastic polymeric network formed through electrostatic interactions. Macromolecules. 2010;43:9529-9533.
31. Cieniecka-Roslonkiewicz A, Pernak J, Kubis-Feder J, et al. Synthesis, anti-microbial activities and anti-electrostatic properties of phosphonium-based ionic liquids. Green Chem. 2005;7:855-862. (Pubitemid 41802837)
32. Bradaric CJ, Downard A, Kennedy C, et al. Industrial preparation of phosphonium ionic liquids. Green Chem. 2003;5:143-152. (Pubitemid 37487470)
33. CLSI/NCCLS. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard. CLSI/NCCLS Document M38-A. Vol 22. Wayne, PA: Clinical and Laboratory Standards Institute; 2005.